0001477449-24-000128.txt : 20240524
0001477449-24-000128.hdr.sgml : 20240524
20240524162732
ACCESSION NUMBER: 0001477449-24-000128
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240523
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evans Jason Eric
CENTRAL INDEX KEY: 0001670094
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 24984805
MAIL ADDRESS:
STREET 1: 310 SEVEN SPRINGS WAY, SUITE 500
CITY: BRENTWOOD
STATE: TN
ZIP: 37027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1716582440.xml
FORM 4
X0508
4
2024-05-23
0
0001477449
Teladoc Health, Inc.
TDOC
0001670094
Evans Jason Eric
C/O TELADOC HEALTH, INC.
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
0
0
0
0
Restricted Stock Units
2024-05-23
4
A
0
17467
0
A
Common Stock
17467
17467
D
Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
The restricted stock units vest in full on the earlier of (i) May 23, 2025 and (ii) the day immediately preceding the issuer's 2025 annual meeting of stockholders. Vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2024-05-24